3M (NYSE: MMM) responded to public accusations concerning its efforts to market BacLite, a product it acquired from Acolyte Biomedica ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE